361 related articles for article (PubMed ID: 25732659)
1. Implication of nanofibers in oral drug delivery.
Kapahi H; Khan NM; Bhardwaj A; Mishra N
Curr Pharm Des; 2015; 21(15):2021-36. PubMed ID: 25732659
[TBL] [Abstract][Full Text] [Related]
2. Electrospun nanofibers in oral drug delivery.
Ignatious F; Sun L; Lee CP; Baldoni J
Pharm Res; 2010 Apr; 27(4):576-88. PubMed ID: 20143253
[TBL] [Abstract][Full Text] [Related]
3. Nanofibers: An Effective Tool for Controlled and Sustained Drug Delivery.
Singh A; Rath G; Singh R; Goyal AK
Curr Drug Deliv; 2018 Feb; 15(2):155-166. PubMed ID: 28969554
[TBL] [Abstract][Full Text] [Related]
4. Progress in the design and development of "fast-dissolving" electrospun nanofibers based drug delivery systems - A systematic review.
Balusamy B; Celebioglu A; Senthamizhan A; Uyar T
J Control Release; 2020 Oct; 326():482-509. PubMed ID: 32721525
[TBL] [Abstract][Full Text] [Related]
5. Self-inflating floating nanofiber membranes for controlled drug delivery.
Tort S; Han D; Steckl AJ
Int J Pharm; 2020 Apr; 579():119164. PubMed ID: 32081796
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin electrospun nanofibers for colonic drug delivery: In vitro dissolution studies.
Akhgari A; Heshmati Z; Afrasiabi Garekani H; Sadeghi F; Sabbagh A; Sharif Makhmalzadeh B; Nokhodchi A
Colloids Surf B Biointerfaces; 2017 Apr; 152():29-35. PubMed ID: 28064095
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of electrospun nanofibers for drug delivery systems.
Son YJ; Kim WJ; Yoo HS
Arch Pharm Res; 2014 Jan; 37(1):69-78. PubMed ID: 24234913
[TBL] [Abstract][Full Text] [Related]
8. Emerging frontiers in drug release control by core-shell nanofibers: a review.
Monfared M; Taghizadeh S; Zare-Hoseinabadi A; Mousavi SM; Hashemi SA; Ranjbar S; Amani AM
Drug Metab Rev; 2019 Nov; 51(4):589-611. PubMed ID: 31296075
[TBL] [Abstract][Full Text] [Related]
9. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs.
Potrč T; Baumgartner S; Roškar R; Planinšek O; Lavrič Z; Kristl J; Kocbek P
Eur J Pharm Sci; 2015 Jul; 75():101-13. PubMed ID: 25910438
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in electrospun for drug delivery purpose.
Liu M; Zhang Y; Sun S; Khan AR; Ji J; Yang M; Zhai G
J Drug Target; 2019 Mar; 27(3):270-282. PubMed ID: 29798692
[TBL] [Abstract][Full Text] [Related]
11. Electrospun Polymer Blend Nanofibers for Tunable Drug Delivery: The Role of Transformative Phase Separation on Controlling the Release Rate.
Tipduangta P; Belton P; Fábián L; Wang LY; Tang H; Eddleston M; Qi S
Mol Pharm; 2016 Jan; 13(1):25-39. PubMed ID: 26655957
[TBL] [Abstract][Full Text] [Related]
12. Immobilization and Application of Electrospun Nanofiber Scaffold-based Growth Factor in Bone Tissue Engineering.
Chen G; Lv Y
Curr Pharm Des; 2015; 21(15):1967-78. PubMed ID: 25732663
[TBL] [Abstract][Full Text] [Related]
13. Mebeverine-loaded electrospun nanofibers: physicochemical characterization and dissolution studies.
Illangakoon UE; Nazir T; Williams GR; Chatterton NP
J Pharm Sci; 2014 Jan; 103(1):283-92. PubMed ID: 24258335
[TBL] [Abstract][Full Text] [Related]
14. Electrospining of Nanofibrous Meshes Composed of Hypromellose and Poly(vinyl alcohol) for One-Day Release of Cationic Peptide.
Son YJ; Mao W; Kang S; Kim K; Kang H; Kim Y; Yoo HS
J Nanosci Nanotechnol; 2019 Dec; 19(12):7920-7925. PubMed ID: 31196310
[TBL] [Abstract][Full Text] [Related]
15. Core-Sheath Nanofibers as Drug Delivery System for Thermoresponsive Controlled Release.
Lv Y; Pan Q; Bligh SW; Li H; Wu H; Sang Q; Zhu LM
J Pharm Sci; 2017 May; 106(5):1258-1265. PubMed ID: 28131496
[TBL] [Abstract][Full Text] [Related]
16. Electrospun inorganic and polymer composite nanofibers for biomedical applications.
Sridhar R; Sundarrajan S; Venugopal JR; Ravichandran R; Ramakrishna S
J Biomater Sci Polym Ed; 2013; 24(4):365-85. PubMed ID: 23565681
[TBL] [Abstract][Full Text] [Related]
17. Electrospun starch nanofibers: Recent advances, challenges, and strategies for potential pharmaceutical applications.
Liu G; Gu Z; Hong Y; Cheng L; Li C
J Control Release; 2017 Apr; 252():95-107. PubMed ID: 28284833
[TBL] [Abstract][Full Text] [Related]
18. New oral delivery systems for treatment of inflammatory bowel disease.
Friend DR
Adv Drug Deliv Rev; 2005 Jan; 57(2):247-65. PubMed ID: 15555741
[TBL] [Abstract][Full Text] [Related]
19. Controlled Bioactive Molecules Delivery Strategies for Tendon and Ligament Tissue Engineering using Polymeric Nanofibers.
Hiong Teh TK; Hong Goh JC; Toh SL
Curr Pharm Des; 2015; 21(15):1991-2005. PubMed ID: 25732661
[TBL] [Abstract][Full Text] [Related]
20. Electrospun polymer micro/nanofibers as pharmaceutical repositories for healthcare.
Feng X; Li J; Zhang X; Liu T; Ding J; Chen X
J Control Release; 2019 May; 302():19-41. PubMed ID: 30922946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
